HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baojin Zhu Selected Research

ixekizumab

6/2022Psoriasis treatment patterns and outcomes with ixekizumab in a real-world setting: results from a single US dermatology referral practice.
4/2022Long-Term Treatment Patterns Among Patients With Psoriasis Treated With Ixekizumab or Adalimumab: A Real-World Study.
3/2022A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab.
1/2022Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings.
1/2022Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings.
1/2022Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial.
12/2021Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months.
12/2021Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.
1/2021Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry.
1/2021Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baojin Zhu Research Topics

Disease

23Psoriasis (Pustulosis Palmaris et Plantaris)
06/2022 - 01/2016
11Schizophrenia (Dementia Praecox)
01/2009 - 01/2004
9Pain (Aches)
01/2022 - 09/2013
5Rheumatoid Arthritis
09/2019 - 11/2018
3Psoriatic Arthritis
02/2022 - 09/2013
2Fatigue
09/2019 - 11/2018
2Chronic Disease (Chronic Diseases)
09/2019 - 11/2018
2Lung Diseases (Lung Disease)
04/2016 - 03/2011
2Hypertension (High Blood Pressure)
04/2016 - 03/2011
2Acute Coronary Syndrome
11/2011 - 03/2011
2Bipolar Disorder (Manic Depressive Psychosis)
11/2007 - 04/2005
1Axial Spondyloarthritis
01/2022
1Ankylosing Spondylitis
12/2020
1Inflammation (Inflammations)
06/2019
1Infections
01/2019
1Arthralgia (Joint Pain)
11/2018
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2016
1Cataract (Cataracts)
01/2015
1Osteoporotic Fractures
01/2015
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2015
1Myocardial Infarction
11/2011
1Type 2 Diabetes Mellitus (MODY)
04/2011
1Diabetes Mellitus
04/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2011
1Body Weight (Weight, Body)
03/2011
1Atrial Fibrillation
03/2011
1Cognitive Dysfunction
07/2006
1Mania (Manias)
04/2005

Drug/Important Bio-Agent (IBA)

23ixekizumabIBA
06/2022 - 01/2016
11Antipsychotic Agents (Antipsychotics)IBA
01/2009 - 01/2004
9Adalimumab (Humira)FDA Link
04/2022 - 04/2016
6Biological ProductsIBA
02/2022 - 04/2016
5Etanercept (Enbrel)FDA Link
01/2022 - 04/2016
5secukinumabIBA
01/2022 - 12/2019
4Ustekinumab (CNTO 1275)FDA Link
01/2022 - 04/2016
4Interleukin-17 (Interleukin 17)IBA
01/2022 - 03/2020
4baricitinibIBA
09/2019 - 01/2019
4Olanzapine (Zyprexa)FDA Link
11/2007 - 01/2004
3Pharmaceutical PreparationsIBA
03/2022 - 03/2011
3Prasugrel HydrochlorideFDA Link
04/2011 - 03/2011
3Clopidogrel (Plavix)FDA Link
04/2011 - 03/2011
3Risperidone (Risperdal Consta)FDA LinkGeneric
11/2007 - 01/2004
2Antirheumatic Agents (DMARD)IBA
02/2022 - 09/2013
2Methotrexate (Mexate)FDA LinkGeneric
06/2019 - 04/2016
1guselkumabIBA
03/2022
1Tumor Necrosis Factor InhibitorsIBA
01/2021
1Interleukin-12 (IL 12)IBA
10/2020
1InterleukinsIBA
10/2020
1Monoclonal AntibodiesIBA
03/2020
1N-phthaloylglutamic acidIBA
11/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2016
1Infliximab (Remicade)FDA Link
04/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015
1Prednisone (Sone)FDA LinkGeneric
01/2015
1Antihypertensive Agents (Antihypertensives)IBA
09/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2013
1Adenosine Diphosphate (ADP)IBA
11/2011
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2011
1MetalsIBA
03/2011
1ziprasidone (Geodon)FDA Link
11/2007
1Quetiapine Fumarate (Seroquel)FDA Link
11/2007
1Antidepressive Agents (Antidepressants)IBA
07/2006
1Illicit Drugs (Recreational Drugs)IBA
07/2006
1Valproic Acid (Depakote)FDA LinkGeneric
04/2005

Therapy/Procedure

8Therapeutics
03/2022 - 04/2011
2Biological Therapy
01/2021 - 09/2013
2Percutaneous Coronary Intervention
11/2011 - 03/2011
2Polypharmacy
04/2008 - 05/2005
1Phototherapy (Light Therapy)
01/2021
1Immunomodulation
09/2019
1Aftercare (After-Treatment)
12/2016
1Stents
03/2011